Institutional Ownership Sab Biotherapeutics Inc Wt Exp (SABSW)
This table provides information about the institutional ownership of Sab Biotherapeutics Inc Wt Exp (SABSW). We have compiled data on the 12 institutions that hold shares in the stock, with a total of 620,526 shares, which have been reported (via 13F filing form) to have a value of $55,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Hb Wealth Management, LLC
|
Oct 15, 2024 Q3 2024 |
310,000
shares
|
$15,500
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
146,439
shares
|
$7,321
0.0% of portfolio
|
Q2 2024
Reduced 1.68%
|
|
|
Yakira Capital Management, Inc.
Westport, CT |
Nov 13, 2024 Q3 2024 |
108,485
shares
|
$5,424
0.0% of portfolio
|
Q1 2022
Reduced 6.3%
|
|
|
Walleye Capital LLC
Plymouth, MN |
Nov 14, 2024 Q3 2024 |
23,258
shares
|
$1,162
0.0% of portfolio
|
Q4 2021
New holding
|
|
|
Wolverine Asset Management LLC
|
Nov 04, 2024 Q3 2024 |
15,519
shares
|
$775
0.0% of portfolio
|
Q3 2024
Added 1.31%
|
|
|
Walleye Trading LLC
Plymouth, MN |
Nov 14, 2024 Q3 2024 |
15,505
shares
|
$775
0.0% of portfolio
|
Q4 2021
New holding
|
|
|
New Edge Advisors, LLC
New Orleans, LA |
Nov 14, 2024 Q3 2024 |
1,072
shares
|
$53
0.0% of portfolio
|
Q4 2022
New holding
|
|
|
Clear Street LLC
|
Nov 14, 2024 Q3 2024 |
200
shares
|
$10
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Tower Research Capital LLC (Trc)
New York, NY |
Nov 14, 2024 Q3 2024 |
48
shares
|
$2
0.0% of portfolio
|
Q4 2021
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Oct 10, 2024 Q3 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q3 2024
New holding
|